Published 16 hours ago • loading... • Updated 16 hours ago

Eye Insert Missed Its Main Vision Goal in a Late Stage Trial but Cut Injections Sharply

EyePoint's DURAVYU missed its primary vision endpoint in the LUGANO trial for wet AMD, despite reducing injection burden by 42 percent.

1 Articles

Medical Daily

Center

Eye Insert Missed Its Main Vision Goal in a Late Stage Trial but Cut Injections Sharply

EyePoint's DURAVYU missed its primary vision endpoint in the LUGANO trial for wet AMD, despite reducing injection burden by 42 percent.

16 hours ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources1

Leaning Left0Leaning Right0Center1Last Updated9 hours agoBias Distribution

100% Center

Bias Distribution

100% of the sources are Center

100% Center

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Medical Daily broke the news 16 hours ago on Wednesday, August 19, 2026.

Sources are mostly out of (0)

Eye Insert Missed Its Main Vision Goal in a Late Stage Trial but Cut Injections Sharply

1 Articles

1 Articles

Eye Insert Missed Its Main Vision Goal in a Late Stage Trial but Cut Injections Sharply

Coverage Details

Bias Distribution

Factuality

Ownership

More stories like this

Congo to receive 70,000 doses of Ervebo Ebola vaccine which has been effective in past outbreaks

California Parents Sue Surrogate After HLHS Diagnosis and Texas Birth

Weekly type 2 diabetes jab could replace daily injections

AMD Appoints Tim Ryan to Board of Directors

Doctors sound alarm over children vaping as studies find wide range of health impacts

Intel Core Ultra 9 4950K Points To New Naming Scheme For Nova Lake-S Desktop CPUs, Alleged ES Chip Faster Than All Current-Gen Chips

Similar News Topics

Similar News Topics

More stories like this

Congo to receive 70,000 doses of Ervebo Ebola vaccine which has been effective in past outbreaks

California Parents Sue Surrogate After HLHS Diagnosis and Texas Birth

Weekly type 2 diabetes jab could replace daily injections

AMD Appoints Tim Ryan to Board of Directors

Doctors sound alarm over children vaping as studies find wide range of health impacts

Intel Core Ultra 9 4950K Points To New Naming Scheme For Nova Lake-S Desktop CPUs, Alleged ES Chip Faster Than All Current-Gen Chips

Eye Insert Missed Its Main Vision Goal in a Late Stage Trial but Cut Injections Sharply

1 Articles

1 Articles

Eye Insert Missed Its Main Vision Goal in a Late Stage Trial but Cut Injections Sharply

Coverage Details

Bias Distribution Too Big Arrow Icon

Factuality Info Icon

Ownership

More stories like this

Congo to receive 70,000 doses of Ervebo Ebola vaccine which has been effective in past outbreaks

California Parents Sue Surrogate After HLHS Diagnosis and Texas Birth

Weekly type 2 diabetes jab could replace daily injections

AMD Appoints Tim Ryan to Board of Directors

Doctors sound alarm over children vaping as studies find wide range of health impacts

Intel Core Ultra 9 4950K Points To New Naming Scheme For Nova Lake-S Desktop CPUs, Alleged ES Chip Faster Than All Current-Gen Chips

Similar News Topics

Similar News Topics

More stories like this

Congo to receive 70,000 doses of Ervebo Ebola vaccine which has been effective in past outbreaks

California Parents Sue Surrogate After HLHS Diagnosis and Texas Birth

Weekly type 2 diabetes jab could replace daily injections

AMD Appoints Tim Ryan to Board of Directors

Doctors sound alarm over children vaping as studies find wide range of health impacts

Intel Core Ultra 9 4950K Points To New Naming Scheme For Nova Lake-S Desktop CPUs, Alleged ES Chip Faster Than All Current-Gen Chips

Bias Distribution

Factuality